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The role of Intra Operative Cholangiogram during laparoscopic cholecystectomy remains controversial.
This review discusses the modalities used in the pre- and peri-operative assessment of Common Bile
Duct. It also discusses the advantages and disadvantages of selective and routine IOC. In this review we
explore the role of Intra Operative Cholangiogram in current day practice.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Although laparoscopic cholecystectomy is the gold standard for
treatment of gall stones, there is no consensus among clinicians
regarding the need for routine IOC and the subsequent treatment of
Common Bile Duct stones.
Intra Operative Cholangiogram during laparoscopic cholecys-
tectomy identiﬁes unsuspected silent CBD stones as well as giving
a better deﬁnition of the extra hepatic biliary anatomy which may
help surgeons to avoid incidental injury to bile duct. The use of IOC
may be routine or in selective patients where CBD stones are sus-
pected on clinical grounds or when anatomy appears unclear at
operation.
In current day practice the role of Intra Operative cholangiogram
during routine laparoscopic Cholecystectomy remains controversial.
Routine IOC has been shown to have number of disadvantages
namely increased cost, operating time and false positive results
leading to unnecessary Common Bile Duct exploration or ERCP.1
The advocates of routine IOC claim that it (a) protects against
bile duct injuries or at least identiﬁes injuries at an early stage2,3
and minimizes the extent and the consequence of the injury (b)
reduces the incidence and morbidity associated with retained CBDSt Helier University Hospital,
ngdom.
das).
ciates Ltd. Published by Elsevier Ltstones (c) decreases the anguish over the patients with recurrent
postoperative symptoms or complications if IOC has been done
successfully.2. Incidence of CBD stones
The overall incidence of silent retained Common Bile Duct
stones in a non-jaundiced patient with normal ducts on trans-
abdominal Ultrasound is around 4%4e6 and only 15% of the patients
with silent retained CBD stones go on to cause problem.4 The
prevalence of asymptomatic bile duct stones in western population
is between 5.2 and 12%.73. Methods of Common Bile Duct imaging
In order to select from the various diagnostic options for
detecting CBD stones, patients may be classiﬁed pre-operatively
into high, intermediate (moderate) or low risk groups. The high risk
(>50% risk) group includes those patients with obvious clinical
Jaundice or cholangitis, Choledocholithiasis or a dilated CBD on
ultrasound. The intermediate risk (10e50%) group includes those
patients with a history of pancreatitis or Jaundice, elevated pre-
operative bilirubin and alkaline phosphatase levels or multiple
small gall stones. The low risk group (<5%) includes patients with
large gall stones without history of Jaundice or pancreatitis and
with a normal liver function tests.8d. All rights reserved.
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USS is the investigation used most widely to conﬁrm the diag-
nosis of gall stones. The USS may give indirect evidence of presence
of CBD stones like dilated CBD or intrahepatic biliary duct dilata-
tion. The sensitivity of USS detecting biliary dilatation from various
study varies from 55 to 91%.9 Its reliability to detect CBD stone
varies from 23 to 80% depending on the body habitus and experi-
ence of the ultrasonographer.10 The CBD diameter of greater than
6 mm on USS is associated with a higher prevalence of
choledocholithiasis.11
3.2. CT scan
CBD stones can be detected on CT scan and often the diameter of
the CBD can be measured. The sensitivity of CT scan in identifying
CBD stone is around 75%.12 The sensitivity of helical CT cholangi-
ography can be as high as 95.5% but not widely used because of the
side effects with the contrast and the availability of MRCP.13
3.3. Magnetic Resonance Cholangiopancreatography (MRCP)
MRCP is a diagnostic modality that offers several advantages
over other imaging techniques for the detection of Common Bile
Duct. It is non-invasive, does not require radiation or intravenous
contrast and depicts accurately the biliary-pancreatic tree and
surrounding anatomy. Given the increasing availability and accu-
racy the European Association of Laparoscopic Surgeons now
consider MRCP to be the standard diagnostic test for patients with
an intermediate probability of CBD stones.14 It is likely that MRCP is
almost as good as ERCP in the diagnosis of CBD stones, though the
ability of MRCP to consistently detect stones of a fewmillimeters in
diameter has yet to be demonstrated. MRCP has a sensitivity of
81e100% and speciﬁcity of 92e100% in detecting CBD stones.15
3.4. Endoscopic Ultrasound (EUS)
EUS appears comparable to ERCP as a diagnostic test for CBD
stones and performs better than either transabdominal USS and CT
scan.16,17 When CT is compared with EUS (and ERCP or IOC is used
as the reference standard), EUS appears a more sensitive test,
particularly in patients with normal calibre Common Bile Ducts and
ductal stones less than 1 cm in diameter.16,17 The disadvantage of
EUS are a) It is operator dependent b) less widely available c) Vis-
ualisation of all segments of biliary tract may be incomplete or
unsuccessful.18 The sensitivity and the speciﬁcity of EUS in
detecting CBD stones is 88e97% and 96e100% respectively.19
3.5. Laparoscopic Ultrasound (LUS)
Laparoscopic Ultrasound is a relatively non-invasive, cost
effective procedure that can be performed safely, quickly and
repeatedly. The accuracy of laparoscopic USS in evaluating CBD
stones during laparoscopic cholecystectomy ranges from 83% to
98% which is equivalent to IOC.20 The advantages of laparoscopic
USS over IOC are a) It can be performed at any time even before the
start of the dissection of the calots triangle b) No exposure to
ionizing radiation c) No need for cystic duct cannulation d) Time
consumed for Laparoscopic Ultrasound is less than that for IOC e)
Cost effective than IOC. The disadvantages of laparoscopic ultra-
sonography a) learning curve associated with the initial use b)
inability to identify the structural variation in the bile duct
anatomy21 c) Need for special equipment d) Operator dependent e)
inability to conﬁrm the ﬂow of bile in to the duodenum.3.6. Intra Operative Cholangiogram (IOC)
IOC is the most classic method intraoperatively to detect CBD
stones. The ﬁrst Intra Operative Cholangiogram was reported in
1936 by Micken. Mirrizi in 1937 performed the ﬁrst cystic duct
cholangiogram22 and this procedure remains the most accepted
method of performing IOC today. The technique has developed
from static views to dynamic real time ﬂuoroscopic cholangiog-
raphy and recently to three-dimensional dynamic cholangiography.
IOC has high sensitivity in detecting CBD stones but its routine use
is associated with increased costs and operation room time. The
failure rate of non-selective IOC is about 15% according to some
reports.23 The failure to perform IOC is due to adhesions in the
calots triangle, closure of the cystic duct or difﬁculty in the
dissection of the cystic duct Although a normal IOC is very
suggestive of disease free Common Bile Duct (CBD), abnormal
studies are associatedwith high false positive rates .The rate of false
positive IOC incorrectly suggesting CBD stones is variable from 2 to
16%.24 In a recently concluded study by Per Videhult et al. the rate of
false positive IOC was 5%. Sensitivity and speciﬁcity of IOC has been
reported at 97% and 99% respectively.25
3.7. Endoscopic Retrograde Cholangiopancreatography (ERCP)
ERCP is considered the gold standard in CBD imaging but should
be reserved for patients with high probability of therapeutic
intervention. The recognised complications of ERCP are post ERCP
pancreatitis (5%), gastrointestinal haemorrhage, cholangitis,
duodenal perforation and miscellaneous including cardio-respira-
tory.26 The overall procedure related mortality is less than 1%.27
4. Discussion
IOC and ERCP are generally considered to be reference standards
for the diagnosis of CBD stones. However routine instrumentation
of the biliary system particularly in patients with low pretest
probability of disease is undesirable.28
Routine pre-operative evaluation of the bile duct seems
unnecessary before laparoscopic cholecystectomy in patients with
uncomplicated gall stone disease.5
A number of authors have tried to develop scoring systems to
predict which patients undergoing laparoscopic cholecystectomy
are likely to have CBD stones to allow the selective use of IOC.29,30
Two similar scoring systems to predict CBD stones in patients with
gall stones were developed separately by Sun et al. and Sarli
et al.29,30 Sun et al. demonstrated that CBD stones occurred in 77%
of the patients with abnormal liver enzymes and pre-operative CBD
dilatation. Analysis by some researchers has shown that sex, serum
transaminase, alkaline phosphatase, bilirubin and CBD diameter on
USS were independent predictors of choledocholithiasis.31 Sarli
et al.30 also classiﬁed gallbladder stones as dangerous when there
are multiple stones and some of them less than 5 mm in size. Liv-
ingston et al.32 reported that a history of simple pancreatitis or
Jaundice was not an indication for biliary exploration in patients
with normal liver enzymes and pre-operative CBD diameters.
With regard to MRCP and EUS in diagnosis of CBD stones,
systematic review of prospective studies has failed to show
a statistically signiﬁcant difference in performance when the two
modalities are compared though for small CBD stones EUS may still
be sensitive.33e35
Increasing availability of MRCP either pre- or post-operatively
provides the surgeon with highly accurate and risk free investiga-
tion for CBD stones.
The incidence of CBD injury following laparoscopic cholecystec-
tomy is around 0.2e0.7% when compared to open cholecystectomy
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common and the incidence reported in the literature around
10e28%.41,42 Thishasoftenbeen cited as a justiﬁcation for the routine
use of Intra Operative cholangiogram during cholecystectomy to
reduce the incidence of bile duct Injury.43e45 However review of
literature does not show any association between the occurrence of
anomalous anatomy and bile duct injuries.4
From a careful prospective analysis of 1200 lap cholecystecto-
mies, Wright and Wellwood concluded that meticulous dissection
of calots triangle is a more reliable safeguard against bile duct
injuries than routine IOC.46 If the ductal anatomy is unclear IOC and
or open conversion should be performed.
When an IOC suggests CBD stone and none was found on
subsequent ERCP, this may be due to false positive results or
spontaneous passage of CBD stone through the sphincter of Oddi in
the interval between laparoscopic cholecystectomy and ERCP.
Collin C et al. concluded that treatment decision based on
assessment by IOC alone would result in unnecessary intervention
in 50% of patients who had either false positive studies or subse-
quently passed the stone.6 The false positivity may be due to air
bubbles mimicking stones or failure of the contrast to drain into the
duodenum, whichmay be relate to papillary stenosis rather than an
impacted stone. One third of the patients with CBD stone at the
time of cholecystectomy pass their stones spontaneously within 6
weeks of surgery.6
The ﬁnancial cost to diagnose silent CBD stone is around half
a million US dollars.47 In a randomised study by Murison, patients
who were undergoing cholecystectomy, but without symptoms of
Common Bile Duct stones, were randomised to IOC or no IOC.
Common Bile Duct stones were discovered in 12% of patients in the
IOC group. It is assumed that similar percentage of patients in the
group without IOC had stones but none developed symptoms over
3 year follow up.48
Based on the Washington State data, it is estimated that 714
IOC’s are required to prevent/identify one CBD injury.49 Livingston
et al. estimated that IOC’s cost US $706 per case such that US
$504,084 must be expended to avoid a complication that costs
approximately US $300,000 to treat.50 These ﬁgures argue against
routine IOC as a cost effective strategy for CBD injury.
If CBD stones are identiﬁed at the time of laparoscopic chole-
cystectomy, the options include laparoscopic Common Bile Duct
exploration at the time of surgery, peri-operative ERCP, post-
operative ERCP,28 open conversion and Common Bile Duct explo-
ration or an observational policy with monitoring of the liver
function tests.51 Two randomised trials have clearly demonstrated
that the laparoscopic approach to bile duct stones has no difference
in the outcome of patients as compared with pre- and post-ERCP
management of bile duct stones andmay in fact results in a reduced
hospital stay.35,52 Open CBD exploration remains an important
technique for managing bile duct stones that are unsuitable for
endoscopic removal or that are unable to be removed at ERCP.28
The optimal technique for bile duct clearance should be based
on the local availability of expert endoscopists, surgical expertise in
laparoscopic CBD surgery and general condition of the patient.
Some of the studies have shown that selective or on demand ERCP
would be better option than routine ERCP for evaluation of the IOC
abnormalities because most small stones will migrate
spontaneously.53e56
In the absence of elevated LFTs, less invasive test such as MRCP
or EUS should be used for the evaluation of patients with abnormal
IOC to minimize unnecessary ERCP.51
In a subset of patients with positive IOC during laparoscopic
cholecystectomy observational policy with monitoring of the liver
function tests may be appropriate to avoid unnecessary invasive
intervention of the bile duct.515. Conclusion
Because of the incidence of CBD stones in patients with chole-
lithiasis is low and CBD injury is infrequent, the beneﬁt of routine
IOC has been difﬁcult to justify in patients with uncomplicated gall
stone disease.
The routine IOC results in increased cost, prolongs operative
times, exposure to ionizing radiation especially in females of child
bearing age group, imagemisinterpretation leading to false positive
studies, contrast related complications and risk of IOC related
biliary injury without clear beneﬁts.
There is no convincing data to suggest that routinely performed
IOC reduces the incidence of retained CBD stones after laparoscopic
cholecystectomy.4,57,58 Meticulous dissection of the calots triangle
is a more reliable safeguard against bile duct injuries than routine
IOC.46
We believe that routine IOC in order to detect coincidental CBD
stones is not required in patients without clinical, biochemical or
radiological evidence of ductal stones. All patients with interme-
diate and high risk of CBD stones should have a pre-operative
MRCP.
It is clear that combination of positive factors (dilated CBD on
ultrasound, clinical Jaundice, raised alkaline phosphatase, raised
bilirubin and cholangitis) pre-operatively may give an indirect
evidence of Common Bile Duct stone.59 This may guide the surgeon
to do pre-operative MRCP or selective IOC.
The revised role of IOC in current day practice is a) In patients
with high and intermediate risk of CBD stones who have not had
a pre-operative MRCP b) If ductal anatomy is unclear during lapa-
roscopic cholecystectomy.
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